Pathophysiology of lymphedema—Is there a chance for medication treatment? Review uri icon

Overview

MeSH Major

  • Lymphedema

abstract

  • Lymphedema is a common morbid after cancer treatment. The disease characterizes with progressive inflammatory process that result in irreversible fibrosis. Its chronology and progressive disease character often impacts the quality of life of cancer survivors. The pathophysiology of lymphedema remains unclear and the disease remains non-curable. In this article, we reviewed available studies of lymphedema and concluded possible treatment strategies for lymphedema. J. Surg. Oncol. 2017;115:96-98. © 2016 Wiley Periodicals, Inc.

publication date

  • January 2017

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/jso.24414

PubMed ID

  • 27566412

Additional Document Info

start page

  • 96

end page

  • 98

volume

  • 115

number

  • 1